Fox Run Management, L.L.C. Aurinia Pharmaceuticals Inc. Transaction History
Fox Run Management, L.L.C.
- $553 Million
- Q2 2025
A detailed history of Fox Run Management, L.L.C. transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Fox Run Management, L.L.C. holds 35,861 shares of AUPH stock, worth $424,594. This represents 0.05% of its overall portfolio holdings.
Number of Shares
35,861
Previous 44,962
20.24%
Holding current value
$424,594
Previous $361,000
16.07%
% of portfolio
0.05%
Previous 0.06%
Shares
9 transactions
Others Institutions Holding AUPH
# of Institutions
250Shares Held
62.6MCall Options Held
1.03MPut Options Held
666K-
Tang Capital Management LLC San Diego, CA10MShares$119 Million5.09% of portfolio
-
Black Rock Inc. New York, NY9.27MShares$110 Million0.0% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$47 Million2.79% of portfolio
-
State Street Corp Boston, MA2.8MShares$33.1 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.4MShares$28.4 Million0.0% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $1.68B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...